Tom Lawry

Tom Lawry • January 9, 2024

Generative AI and Precision Medicine – The Future is Not What It Used to Be

“When we look back in (the year) 2041, we will likely see healthcare as the industry most transformed by AI." 

                                                                                                                                           - Kai-Fu Lee, AI 2041


Generative AI is a new and rapidly emerging form of artificial intelligence that has the potential to revolutionize precision medicine by improving diagnosis, treatment, and drug discovery. It’s comprised of Large Language Models and other intelligent systems that replicate a human's ability to create text, images, music, video, computer code, and more.


So, naturally, when Damian Doherty, Editor-in-Chief of Inside Precision Medicine, approached me last fall about writing an article on Generative AI, the first thing I did was ask the latest version of ChatGPT to provide a 2,800-word manuscript on the opportunities and issues of its application to precision medicine.


The content it generated was relevant, logically organized, and backed up with factual information. Sentence structures were precise and delivered in an easy-to-understand format. There was a formulaic beginning, middle, and end, with the correct provisos stated for being wrong.

The result was quite good, but in the end, it was a little too GPT-ish. There were many things my human brain wanted to know that it didn’t cover or guide me towards.


In some ways, this exercise mirrors the deeper discussions and explorations that are just getting underway to both understand our new and evolving AI capabilities and define a logical pathway to help clinicians and researchers make the practice of medicine more precise.

I’ve had the benefit of working with the application of AI in health and medicine for over a decade. Here are my very human thoughts on what should be considered as we approach this opportunity.


An AI Taxonomy


Generative AI is a relatively new form of AI that has been released into the wild. As such, there are very few experts. This means that we are all early in the journey of understanding what it is and how we apply it to do good.

The chart below provides a simple taxonomy to help differentiate generative AI from other forms of Predictive Analytics.

While there is a great deal of hype over generative AI, there is a growing body of evidence on the things it can do well with humans in the loop:[i]

•       Write clinical notes in standard formats such as SOAP (subjective, objective assessment and plan)

•       Assign medical codes such as CPT and ICD-10

•       Generate plausible and evidence-based hypotheses

•       Interpret complex laboratory results

Going forward generative AI will provide benefits in many areas including:


Drug Discovery and Development: Assistance in the discovery of new drugs and their development by predicting molecular structures, simulating drug interactions, and identifying potential drug candidates more quickly and accurately. AI can identify existing drugs that could be repurposed for new therapeutic uses, potentially speeding up the drug development process and reducing costs.


Personalized Treatment Plans: Analyze large-scale patient data, including genetic information, medical records, and imaging data, to guide physicians in the creation of personalized treatment plans tailored to an individual's unique genetic makeup and health profile.


Disease Diagnosis: Assistance in the early and accurate diagnosis of diseases by analyzing medical images, genomic data, and clinical records, helping healthcare professionals make more informed decisions.

 

Medicine has Been Here Before – Change is Hard


Since medicine came out of the shadows and into the light as a data-driven, scientific discipline we’ve always aspired to be better. The reality is that change is hard. It requires us to think and act differently.


When cholera was raging through London in the 1850’s Dr. John Snow was initially rebuffed when he challenged the medical establishment by gathering and presenting data demonstrating that the root cause of cholera was polluted water rather than the prevailing view that it was caused by bad air. From this came the early stages of epidemiology.[ii]

 

In the 1970’s the introduction of endoscopy into surgical practice was met with resistance in the surgical community which saw little use for “key-hole” surgery as the prevailing view and practice was that large problems required large incisions. Today, the laparoscopic revolution is seen as one of the biggest breakthroughs in contemporary medical history.[iii]

 

Generative AI and Large Language Models are part of medicine’s next frontier. They are already challenging current practices across the spectrum of research, clinical trials, medical and nursing school curricula, and the front-line practice of medicine. It’s not a matter of whether it will affect what you do but rather how and when.

 

With the right dialogue and guidance from a diverse set of stakeholders, we will create a path forward that leverages the benefits of our evolving creations to improve health and medical practices while ensuring that appropriate guardrails are put in place to monitor and guide its use.

 

It’s Not About Going Slow. It’s About Getting Things Right


In some ways, the challenge of generative AI today is less about increased AI capabilities and more about the velocity of change it is driving.

Generative AI came screaming into mainstream consciousness in the fall of 2022. ChatGPT, a generative AI product from OpenAI, racked up 100 million users in two months. In the history of humans, there has never been a product that has seen such rapid adoption. Shortly after ChatGPT reached this milestone the next version of GPT was released with greatly increased capabilities.


From the practice of medicine to the development of new drugs, generative AI’s “speed of progress” is not following the normal path that economists refer to as linear growth.  This is where something new is created that adds incremental value, which then creates a small gap between the time of its creation and when it starts being used. As adoption occurs there is another small gap between uptake and the time it takes for policymakers to develop necessary guard rails to both guide its use and safeguard users from risks. Linear growth is steady and predictable and what clinical and operational systems are set up to manage.


Generative AI is upending linear growth. It’s taking a different trajectory that economists call exponential growth. This is where something increases faster as it gets bigger. Most of our systems are not designed to accommodate this dramatic escalation in change. Exponential growth doesn’t last and eventually, the pace of change returns to linear growth. But when it’s happening it feels like the world is inside a tornado.

The European Parliament approved landmark rules for artificial intelligence, known as the EU AI Act which aims to bring generative AI tools under greater restrictions. This includes generative AI developers being required to submit these systems for review before releasing them commercially.[iv]Here in the United States the Biden administration issued an Executive Order last fall to build momentum within federal agencies and the private sector to put better guardrails in place for the use of AI.


The rapid change driven by generative AI has some calling for measures to slow or even suspend AI development to evaluate its impact on humans and society. A petition from the Future of Life Institute was put forward and signed by leaders including Elon Musk calling for a six-month moratorium on AI development.[v]

 

While there is uncertainty in what we are creating and how it should be applied, it is unlikely that any mandates will slow the pace of AI innovation.


Instead of attempting to slow progress, let us expedite the education and dialogue among policymakers, medical and research leaders, and frontline practitioners to chart a course for progress in applying our new intelligent capabilities. These groups are also most relevant to ensuring that a necessary set of laws, regulations, and protocols are in place to safeguard those both providing and receiving health and medical services.


The Creation of Enforceable Responsible AI Principles


Let’s recognize and support the overall good that can come from AI innovation. At the same time, we must be mindful of how our ever-expanding AI capabilities can replicate and even amplify human biases and risks that work against the goal of improving the health and well-being of all citizens.


Prioritizing fairness and inclusion in AI systems is a socio-technical challenge. The speed of progress is spawning a new set of issues for governments and regulators. It’s also challenging us with new ethical considerations in the fields of medical and computer science. Ultimately the question is not only what AI can do, but rather, what AI should do.


While legislators and regulators work on finding common ground, health and medical organizations using AI today should have a defined set of Responsible AI principles in place to guide the development and use of intelligent solutions. Most often, these principles or guidelines are reviewed and approved at the highest level of leadership and incorporated into an organization’s overall approach to Data Governance.


AI in Medicine is Not About Technology. It’s About Empowerment


AI has a PR problem. The narrative in the popular press and professional journals is often negative.  Headlines like “Half of U.S. Jobs Could be Eliminate With AI,” paint a picture of a future work world dominated by what novelist Arthur C. Clarke calls robo-sapiens.[vi] [vii]


It’s no wonder that people are worried. According to a study by the American Psychological Association, the potential impacts that AI could have on the workplace and jobs is now one of the top issues impacting the mental health of workers.[viii]


Generative AI is already impacting today’s workplace and will be the single greatest change affecting the Future of Work in the next decade. It will impact how all work is done. As you let that statement sink in, recognize that the issues to be addressed go beyond productivity. After all, work brings shape and meaning to our lives and is not just about a job or income.


In this regard, there is growing evidence to suggest that AI can increase not only productivity but also job satisfaction.


In a randomized trial using generative AI, 453 college-educated professionals were given a series of writing tasks to complete. Half were given support with ChatGPT. The control group was not given access to Chat GPT. The results showed that the time taken to complete tasks was reduced by 40% among those using this form of generative AI. Beyond increased productivity, those using ChatGPT reported an increase in job satisfaction and a greater sense of optimism. Most importantly, inequality between workers decreased.[ix]


Done right, AI is not about technology. It’s about empowerment. Properly curated, generative AI will help solve one of the most significant challenges facing healthcare - The shortage of human capital.


The effective introduction and use of generative AI in health and medicine enables both cost-cutting automation of routine work and value-adding augmentation of human capabilities. As it and other forms of AI become pervasive in health and medicine, a new intelligent health system will emerge. It will facilitate systems that improve health while delivering greater value. It will provide a more personalized experience for consumers and patients. It will liberate clinicians and restore them to be the caregivers they want to be rather than the data entry clerks we’re turning them into by forcing them to use systems and processes conceived decades ago.


And while generative AI is coming at us fast with much to understand in how we use it, it could not have come at a better time.


The full article written for Inside Precision Medicine may be found at https://www.insideprecisionmedicine.com/topics/precision-medicine/generative-ai-and-precision-medicine-the-future-is-not-what-it-used-to-be/



References Used in This Blog:


[i]   Peter Lee, Carey Goldberg, Isaac Kohane, The AI Revolution in Medicine: GPT-4 and Beyond, Pearson Education, 2023

[ii]  Theodore H. Tulchinsky, MD MPH, John Snow, Cholera, the Broad Street Pump; Waterborne Diseases Then and Now, Case Studies in Public Health, March 30, 2018

[iii] Endoscopic surgery: the history, the pioneers. Litynski GS.World J Surg. 1999 Aug;23(8):745-53. doi: 10.1007/s002689900576.PMID: 10415199

[iv] Ryan Browne, EU lawmakers pass landmark artificial intelligence regulation, CNBC, June 14, 2023, https://www.cnbc.com/2023/06/14/eu-lawmakers-pass-landmark-artificial-intelligence-regulation.html

[v] Pause Giant AI Experiments: An Open Letter, Future of Life Institute, March 22, 2023, https://futureoflife.org/open-letter/pause-giant-ai-experiments/

[vi] http://business.rchp.com/home-2/half-of-all-jobs-eliminated/

[vii] Arthur C. Clark, Britannica, https://www.britannica.com/biography/Arthur-C-Clarke

[viii] Worries about artificial intelligence, surveillance at work may be connected to poor mental health, American Psychological Association, September 7, 2023, https://www.apa.org/pubs/reports/work-in-america/2023-work-america-ai-monitoring

[ix] Shakked Noy, Whitney Zhang, Experimental evidence on the productivity effects of generative artificial intelligence, Science, July 13, 2023, https://www.science.org/doi/10.1126/science.adh2586


By Tom Lawry February 7, 2025
The body content of your post goes here. To edit this text, click on it and delete this default text and start typing your own or paste your own from a different source.
By Tom Lawry February 5, 2025
Excited to be heading to Australia this week as part of a five-city talk tour organized by UBS Australia. They’ve assembled a great lineup of speakers who will be exploring the evolving global landscape in business and health tech. I'm keynoting on what's next for AI. The cities and dates for the tour include: Brisbane: February 12 Adelaide: February 13 Melbourne: February 17 Sydney: February 18 Perth: February 20 Along the way I'll also be catching up with some of my favorite AI and digital health experts who are doing great things "Down Under." Oh yeah… It’s summertime in Australia. Not so much in Seattle. T.
By Tom Lawry January 28, 2025
I’ve been pondering how many journalists and podcasters I’ve ticked off when answering this question: Where will AI be in a year? My answer has always been simple and honest: No one knows. This week the Chinese start-up DeepSeek is the latest shift in AI’s tectonic plates. Seemingly out of nowhere, it became the top-rated AI app in the United States. Deepseek’s new, open-source AI model rivals the abilities of OpenAI's most recent model—with far less investment and using reduced-capacity chips. Training costs for ChatGPT-4 were over $100 million. Deepseek’s investment was supposedly $6 million. Deepseek’s model improves energy efficiency making AI more accessible to more people and industries and could be welcomed news when it comes to AI’s environmental impact. There’s a lot to be learned about Deepseek’s capabilities. For now, it certainly ups the ante in the AI “space race” for global tech titans and governments. I can hear the hype machines starting to churn as I write this. Here’s a solid piece from Scientific American that outlines what is known. And so: Where will AI be in a year? No one knows. T.
By Tom Lawry January 23, 2025
I am pleased to announce that I have a new book coming in April. Whether a patient, health consumer, physician, nurse, health executive, or elected official, somewhere deep in our brains is this simple truth: the American health system isn’t working, and it will only get worse if we don’t do something about it. Despite spending more money per capita on healthcare than any other country in the world, the U.S. struggles to match other nations in life expectancy, health outcomes and general well-being. Meanwhile the system spends more on unnecessary, ineffective and wasteful services than what we collectively invest in K-12 education in America. All the while, our health status is declining. For the first time kids born today may not live as long as their older siblings. Health Care Nation shines a light on the deep interconnectedness between the health of people and the health of a nation. It’s about the opportunity and responsibility each of us has to reimagine and reengineer a system that focuses on keeping all citizens healthy and caring for them when they are not. Health Care Nation takes readers on a journey to understand the fundamental issues driving the system in the wrong direction. It focuses on helping each reader find or sharpen their voice in what should change based on their views, values and experiences. Health Care Nation awakens readers to the possibilities that exist today that are right in front of us if only we choose to see them. It creates an understanding of the forces at work in healthcare today that are driving us in the wrong direction, instilling readers with a sense of activism that mobilizes them to take action. The ultimate goal of this book is to help everyone find and use their voice to drive positive change. Health Care Nation is designed to help readers understand the role they can play and actions they can take to determine the health and economic well-being for generations to come. My publisher is doing an early book launch at the HIMSS conference in Las Vegas March 3-6. Would love to see you if attending. Look for me at the HIMSS bookstore near the exhibit hall. I'll be signing advance copies. Health Care Nation is also available for preorder on Amazon. For more information about the book go to www.healthcarenation.us .
By Tom Lawry January 6, 2025
With January comes a sea of predictions for 2025. Many are insightful, but if you're a health leader tracking AI developments, here are three emerging themes to pay attention to. The Great AI Pivot: From FOMO to Value Since the Fall of 2022, AI hasn’t been just a technological shift—it’s been a cultural phenomenon. Conversations about AI spread from the conference room to the dinner table. Organizations adopted it at breakneck speed, and the fear of missing out (FOMO) drove up to 60% of AI’s recent adoption. One study found that 63% of leaders feared their organizations would fall behind if they didn’t join the AI gold rush. In the coming year, forward-thinking leaders will pivot from pursuing limited-value AI applications to investing in ecosystems of people and processes that generate scalable, repeatable value (think innovation flywheel). This is a different mindset compared to the approach taken by many leaders in the last two years. It’s a recognition that AI is here to stay and that creating “value-at-scale” requires the adoption of a growth mindset for what’s ahead.
By Tom Lawry December 29, 2024
Welcome to 2025! I'm hopeful it's the year that we'll move from AI FOMO (fear of missing out) to focusing on driving value at scale in support of our missions and enterprises. To get started, Deloitte’s 16th annual Tech Trends report is a great quick read. AI is the common thread of nearly every trend. Moving forward, it will be part of the substructure of everything we do. The report is available here . Here's to an intelligent new year! T.
By Tom Lawry August 30, 2024
Looking forward to being back in Singapore next week to speak at/attend APACMed 2024. Healthcare across Asia Pacific is changing. Consumers are increasingly gravitating towards health organizations that provide greater convenience. This includes the use of digital and AI solutions that allow them to be more involved in managing their health.
Intelligent Aging is Healthcare’s Moonshot
By Tom Lawry March 28, 2024
“It's not how old you are, it's how you are old.” - Jules Renard
A close up of a person 's eye in the dark.
By Tom Lawry February 18, 2024
While Shakespeare popularized the phrase “the eyes are the window to your soul,” new research suggests that our eyes may also be a window to predicting cardiac, pulmonary, metabolic, and neuropsychiatric diseases.  Physician-researchers from Harvard Medical School, Mass Eye and Ear, Massachusetts General Hospital, and the Broad Institute of MIT and Harvard have found that they can estimate how likely a person is to develop eye and other systemic diseases by using AI to combine retinal imaging, genetics, and big data. [i ] Retinal imaging is already a commonplace procedure used by Ophthalmologists and Optometrists to evaluate eye health. However, the results of this study suggest its use could be widened. The findings focus on how the thinning of different layers of the retina correlates to an increased risk of developing ocular, cardiac, pulmonary, metabolic, and neuropsychiatric diseases. Previous studies have shown links between retinal health and health conditions, such as aging, cardiometabolic diseases such as diabetes and hypertension, and neurological diseases such as dementia, stroke, and multiple sclerosis. Unlike previous studies that searched for genes associated with overall retinal health, this study delved deeper into the role of the different cell layers that make up the retina. Further research is needed to confirm actual causality, but for now, there is evidence to suggest that retinal imaging might be used in the future to predict and better manage multiple systemic health conditions including poor heart, metabolic, lung, and kidney function. While eye health is critically important on its own, imagine a time when going in for your routine eye examination could also shed light on other areas impacting your future health and well-being. The new study uncovers possibilities for preventive medicine and cross-collaboration between ophthalmology and other areas of medicine. [i] U sing Retinal Images to Predict Risk of Eye and Systemic Diseases, Harvard Medical School News and Research, February 1, 2024, https://hms.harvard.edu/news/using-retinal-images-predict-risk-eye-systemicdiseases
Fixing Healthcare is a Generaltion Thing
By Tom Lawry January 16, 2024
In 2013, the movie “Her” won the Oscar for Best Original Screenplay. The genius of this sci-fi romance was that it took place in the not-too-distant future when the world would be dominated by Millennials (those born between 1982-1997). The movie’s main character, Theodore Twombly (played by Joaquin Phoenix), falls in love with an intelligent operating system named Samantha. We catch glimpses throughout the movie of a future where the Millennials’ love of intelligent technology is ingrained into every aspect of society.
Show More
Share by: